Company: STAA
Filing Date: 2025-12-10
Form Type: DEFA14A
Source: 0001193125-25-314435
Chunk: 16

Company: STAAR SURGICAL CO
Filing Date: 2025-12-10
Form: DEFA14A
Chunk 16
---
 as of immediately prior to
the Effective Time assuming that the performance goals were achieved at the target level of performance by (ii) the RSU Exchange Ratio, with any fractional shares rounded

11

down to the nearest whole share. Each Adjusted PSU Award will otherwise be subject to the same terms and conditions applicable to the corresponding STAAR PSU Award, including vesting terms, as of
immediately prior to the Effective Time, except that the Adjusted PSU Award will no longer be subject to any performance-based vesting conditions. For clarity, the Adjusted PSU Award will be deemed earned at the Effective Time, such that 50% of the
Adjusted PSU Award will become vested on the 15th day of the second month following the quarter in which the Closing Date occurs and, without limiting the applicable “double trigger” vesting protection (whereby vesting will be
accelerated upon a termination of employment within 12 months following the Effective Time due to a termination without cause or a resignation by the award holder for good reason), the remaining 50% will become vested on (subject to continued
service through) the first anniversary of the vesting date for the first 50% in accordance with the terms of the award.

For an estimate
of the value of unvested equity awards held by STAAR’s named executive officers that would vest assuming that the Merger occurs on December 5, 2025 and that the named executive officer experiences a termination of employment without cause
or resignation for good reason on the same day, see “— Quantification of Payments and Benefits to STAAR’s Named Executive Officers” below. We estimate that the aggregate value of unvested equity awards held by all
non-employee directors of STAAR that would vest assuming that the Merger occurs on December 5, 2025 is $2,804,483, calculated based on the Merger Consideration of $30.75 per share.

The section titled “—Quantification of Payments and Benefits to STAAR’s Named Executive Officers” on pages 64-66 of the proxy statement is hereby amended and restated as follows:

The table below sets forth the amount of payments and benefits
that each of STAAR’s named executive officers would receive in connection with the Merger, assuming (i) that the Merger were consummated and each such named executive officer experienced a termination without cause on December 5,
2025; and (ii) a per share price of STAAR common stock of $30.